Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 8:9:744.
doi: 10.3389/fonc.2019.00744. eCollection 2019.

The Role of Metabolic Syndrome in Endometrial Cancer: A Review

Xiao Yang  1 , Jianliu Wang  1
Affiliations
Review

The Role of Metabolic Syndrome in Endometrial Cancer: A Review

Xiao Yang et al. Front Oncol. .

Abstract

Endometrial cancer is one of the most common cancers of the female reproductive system. Although surgery, radiotherapy, chemotherapy, and hormone therapy can significantly improve the survival of patients, the treatment of patients with very early lesions and a strong desire to retain reproductive function or late recurrence is still in the early stages. Metabolic syndrome (MS) is a clustering of at least three of the five following medical conditions: central obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL). Obesity, diabetes and hypertension often coexist in patients with endometrial cancer, which increases the risk of endometrial cancer, also known as the "triple syndrome of endometrial cancer." In recent years, epidemiological and clinical studies have found that MS associated with metabolic diseases is closely related to the incidence of endometrial cancer. However, the key molecular mechanisms underlying the induction of endometrial cancer by MS have not been elucidated to date. Characterizing the tumor metabolism microenvironment will be advantageous for achieving a comprehensive view of the molecular mechanism of metabolic syndrome associated with endometrial cancer and for providing a new target for the treatment of endometrial cancer. This review focuses on recent advances in determining the role of metabolic syndrome-related factors and mechanisms in the pathogenesis of endometrial cancer. We suggest that interfering with the tumor metabolic microenvironment-related molecular signals may inhibit the occurrence of endometrial cancer.

Keywords: endometrial cancer; metabolic microenvironment; metabolic syndrome; signaling pathway; targeted therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dysfunctional adipose tissue in obesity.
Figure 2
Figure 2
Potential pathways directly linking metabolic syndrome with endometrial cancer.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. (2018) 68:7–30. 10.3322/caac.21442 - DOI - PubMed
    1. Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, et al. . USA endometrial cancer projections to 2030: should we be concerned? Future Oncol. (2014) 10:2561–8. 10.2217/fon.14.192 - DOI - PubMed
    1. Tejerizo-Garcia A, Jimenez-Lopez JS, Munoz-Gonzalez JL, Bartolome-Sotillos S, Marqueta-Marques L, Lopez-Gonzalez G, et al. . Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. Onco Targets Ther. (2013) 9:1305–13. 10.2147/OTT.S51532 - DOI - PMC - PubMed
    1. Hao J, Bao X, Jin B, Wang X, Mao Z, Li X, et al. . Ca2+ channel subunit alpha 1D promotes proliferation and migration of endometrial cancer cells mediated by 17beta-estradiol via the G protein-coupled estrogen receptor. FASEB J. (2015) 29:2883–93. 10.1096/fj.14-265603 - DOI - PubMed
    1. Kim JJ, Chapman-Davis E. Role of progesterone in endometrial cancer. Semin Reprod Med. (2010) 28:81–90. 10.1055/s-0029-1242998 - DOI - PMC - PubMed

LinkOut - more resources